TREVI THERAPEUTICS
Trevi Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis (IPF), and levodopa-induced dyskinesia (LID) in patients with Parkinson’s disease. These conditions share common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Trevi is currently conducting a Phase 2b/3 clinical trial of nalbuphine ER, referred to as the PRISM trial, in patients with severe pruritus associated with prurigo nodularis.
TREVI THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Sandy Hook, Connecticut, United States
Country:
United States
Website Url:
http://www.trevitherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
203-304-2499
Email Addresses:
[email protected]
Total Funding:
156.53 M USD
Technology used in webpage:
Font Awesome HSTS IPv6 ReCAPTCHA Cloudflare Hosting Cloudflare JS CDN JS Facebook Sharer Cloudflare CDN ReCAPTCHA V2
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Aviceda Therapeutics
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Fairmount Funds Management
Fairmount Funds Management investment in Post-IPO Equity - Trevi Therapeutics
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Trevi Therapeutics
Frazier Life Sciences
Frazier Life Sciences investment in Post-IPO Equity - Trevi Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Trevi Therapeutics
Omega Funds
Omega Funds investment in Series C - Trevi Therapeutics
TPG Biotech
TPG Biotech investment in Series C - Trevi Therapeutics
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series C - Trevi Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series C - Trevi Therapeutics
TPG Biotech
TPG Biotech investment in Series C - Trevi Therapeutics
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series C - Trevi Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-11-14 | Trevi Therapeutics Appoints Pharma Industry Veteran as Chief Medical Officer |
Official Site Inspections
http://www.trevitherapeutics.com Semrush global rank: 2.79 M Semrush visits lastest month: 6.14 K
- Host name: cloudproxy10117.sucuri.net
- IP address: 192.124.249.117
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Trevi Therapeutics"
Trevi Therapeutics|A Novel Approach to Treat Chronic Cough
Haduvio and Chronic Cough. Chronic cough impacts up to 10% of the adult population and has physical, psychological, and social impacts on patients’ lives.See details»
Trevi Therapeutics - Investor Site - Overview
May 8, 2019 Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvioâ„¢ (oral nalbuphine ER) for the …See details»
Passionate about Progress - Trevi Therapeutics
We are a clinical-stage biopharmaceutical company that is developing the investigational therapy Haduvioâ„¢ (oral nalbuphine ER) to help patients suffering with chronic cough by targeting the central and peripheral cough reflex arc. …See details»
Trevi Therapeutics, Inc. | LinkedIn
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing the investigational therapy Haduvioâ„¢ (oral nalbuphine extended-release) for the treatment of chronic cough in ...See details»
Trevi Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 203-304-2499 Trevi Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious …See details»
Trevi Therapeutics, Inc. (TRVI) - Yahoo Finance
See the company profile for Trevi Therapeutics, Inc. (TRVI) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Trevi Therapeutics (TRVI) Company Profile & Description - Stock …
May 7, 2019 Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough …See details»
Trevi Therapeutics, Inc. Management Team | Org Chart
Trevi Therapeutics, Inc. employs 35 employees. The Trevi Therapeutics, Inc. management team includes Jennifer Good (President and CEO), Katherine Takaki (Vice President, Global …See details»
Trevi Therapeutics, Inc. Company Overview, Contact Details ...
Dec 16, 2024 Trevi Therapeutics, Inc. hired James V. Cassella as Chief Development Officer on Sep 30th '24. NEW HAVEN, Conn., Sept. 30, 2024 /PRNewswire/ - Trevi Therapeutics, Inc. …See details»
Trevi Therapeutics - 2025 Company Profile & Funding - Tracxn
May 2, 2025 Trevi Therapeutics - Developing Nalbuphine ER for the severe chronic itching condition known as pruritus (uremic and nodularis).. Public Company. Raised a total funding of …See details»
Trevi Therapeutics, Inc. Information - RocketReach
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvioâ„¢ (nalbuphine …See details»
Trevi Therapeutics - PitchBook
Trevi Therapeutics General Information Description. Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the …See details»
Trevi Therapeutics - Craft
Oct 29, 2024 Trevi Therapeutics has 5 employees at their 1 location and $14.07 m in annual revenue in FY 2018. See insights on Trevi Therapeutics including office locations, competitors, …See details»
Board of Directors|Trevi Therapeutics
Heffernan held previous positions as Co-Founder and Chief Executive Officer of Clinical Studies Ltd., a pharmaceutical contract research organization that was sold to PhyMatrix Corp, a …See details»
Trevi Therapeutics - Overview, News & Similar companies
Apr 9, 2024 Trevi Therapeutics contact info: Phone number: (203) 304-2499 Website: www.trevitherapeutics.com What does Trevi Therapeutics do? clinical-stage …See details»
Trevi Therapeutics Inc, TRVI:NMQ profile - FT.com - Financial Times
Apr 17, 2025 Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of the investigational therapy …See details»
Trevi Therapeutics to Report Fourth Quarter and Year End 2024
Mar 11, 2025 Investor Contact Jonathan Carlson Trevi Therapeutics, Inc. (203) 654 [email protected] Media Contact Rosalia Scampoli 914-815-1465 …See details»
Trevi Therapeutics Reports First Quarter 2025 Financial Results and ...
5 days ago NEW HAVEN, Conn., May 8, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational …See details»
Contact - Trevi Therapeutics
Trevi Therapeutics is located at: 195 Church Street, 16th Floor New Haven, CT 06510 (203) 304-2499See details»
Life at Trevi|Trevi Therapeutics
Overlooking the New Haven Green, Trevi Therapeutics sits in the center of the New Haven biotech community. New Haven has a rapidly growing life-science industry which is supported …See details»